Reproductive Endocrinology
Product Review
Product Update: Bijuva; Liletta; Aegea Vapor System; Natural Cycles
TREATMENT FOR VASOMOTOR SYMPTOMS
BIJUVA™ has been US Food and Drug Administration (FDA)–approved as the first oral treatment for...
From the Journals
Insulin may be toxic to the placenta in early pregnancy
This insulin toxicity during pregnancy can be prevented with metformin in vitro.
News
FDA expands Essure’s postmarketing surveillance study
The study now will run for 5 years, and the cohort will be expanded to include any woman who receives the device before it’s pulled from U.S....
Conference Coverage
Infertility appears to be increased among women with epilepsy
NEW ORLEANS – An analysis finds an infertility rate of 9.2% among women with epilepsy, compared with 6.0% in the...
From the Journals
PCOS linked to increased cancer risk in premenopausal women
The increased risks appear to subside after menopause.
Commentary
NIH director expresses concern over CRISPR-cas9 baby claim
“Lest there be any doubt, and as we have stated previously, NIH does not support the use of gene-editing technologies in human embryos.”
From the Journals
Levonorgestrel implant right after delivery does not affect breastfeeding, infant growth
There were similar rates of infant growth in both groups at 6 months, and there were no significant between-group differences in time to...
From the Journals
Frozen embryo transfer benefits limited to subgroups
The benefits of frozen versus fresh embryo transfer may be limited to certain subgroups of women.
Conference Coverage
CKD, and even dialysis, may not be barriers to pregnancy
Nephrologist urges colleagues to get a grip on how to counsel patients of child-bearing age.
From the Journals
Concerns over discretion, efficacy lead teen females to use emergency contraception
Latest News
Ob.Gyn. News welcomes Dr. Trolice to the board
Ob.Gyn. News welcomes Mark P. Trolice, MD, to the editorial advisory board.